JOIN OUR TEAM
Kline’s latest Aesthetic Skin Care Consumer Insights 2023: U.S. Survey reveals that in 2023, aesthetic skin care consumers are sophisticated, trend-conscious, and economically aware. The aesthetics industry has responded to tighter budgets by shifting toward lower-cost treatments and skin care products, while wellness services and new beauty trends are gaining popularity, with a focus on
The global medical dispensing skin care market remains buoyant, increasing by a double-digit rate of 11% in 2022, according to our recently published Medical-Dispensing Skin Care: Global Screening Assessment report. Despite challenges such as supply chain and staffing shortages, the market has returned to healthy pre-pandemic growth levels and is inching toward the $3 billion
As we move further away from the recession that resulted in sweeping changes in consumers’ spending habits, the professional skin care industry shows signs of recovery with an estimated 5% increase in overall sales in 2014. Dispensing physicians continue to be the primary source of growth for the industry. The channel is expected to post
Almost one-fourth of dispensing physicians generate over 15% of their revenue from the sales of skin care products. Nearly three-fourths of dispensing physicians want to increase this proportion in 2014 finds Kline’s survey based on hundreds of in-depth interviews with dermatologists, plastic surgeons, and medical spas that sell professional skin care products to their patients.
For the last 25 years, the Professional Beauty Show in London has been serving as the beauty platform for industry professionals and clients to learn about new trends in skin care products and their most efficient application. This year, the show brought together more than 600 brands from every area of the industry including skin
Thousands of deals were announced globally through 2012, and this level of confidence and activity in M&A continues apace into 2013 as exemplified by Valeant’s acquisition of Ambi Skincare Products from Johnson & Johnson and Acne Free from University Medical. Similarly, Valeant has recently announced it is acquiring outstanding Obagi stock for $360 million. Other noteworthy
